Menu Close

Trending

Supreme court throws Novartis a lifeline for Gilenya defense
Frontiers Health Steering Committee spotlight: Eugene Borukhovich
Babylon hires Andrew Hine to spearhead overseas expansion
Merck defends blockbuster Januvia franchise from patent challenge
Relief for Amylyx as FDA clears controversial ALS drug Relyvrio

Nexgen Healthcare Communications

Focus on Rare the invisible burden of rare diseases

Deep Dive/ R&D/ Views & Analysis/ Views and analysis

Focus on Rare: the invisible burden of rare diseases

, , , , , 0 Comment

Emma Sutcliffe from NexGen Healthcare Communications looks at how patient insights can bring the invisible challenges of living

X
Focus on Rare: the invisible burden of rare diseases
https://pharmaphorum.com/r-d/views-analysis-r-d/focus-on-rare-the-invisible-burden-of-rare-diseases/
Welcome-to-Generation-R-for-the-next-decade-of-patient-engagement-1200x675-Feature

Deep Dive/ Patients/ Views and analysis

Welcome to ‘Generation R’ for the next decade of patient engagement

, , , , 0 Comment

Relationship recrudescence; inertia, cynicism and complacency must not prevail, says Nexgen Healthcare Communications’ Emma Sutcliffe “Are patients too

X
Welcome to ‘Generation R’ for the next decade of patient engagement
https://pharmaphorum.com/patients/welcome-to-generation-r-for-the-next-decade-of-patient-engagement-nexgen/

Login

CONTINUE TO SITE >
X
Close in 10 seconds